Table 2.
Clinical data from plasma samples used in microarrays.
| Total of Samples ** | Prostate Cancer | Healthy Donors | |
|---|---|---|---|
| n = 16 | n = 10 | ||
| Age | |||
| Mean | 75.06 | 28.1 | |
| Range | 55–93 | 22–45 | |
| PSA (ng/mL) | |||
| Mean | 84.72 | - | |
| Range | 2.74–566 | - | |
| Gleason Score * | n | % | |
| 3 + 3 | 4 | 57.14 | |
| 3 + 4 | 2 | 28.57 | |
| 4 + 3 | 1 | 14.29 | |
| 4 + 4 | 3 | 42.86 | |
| 4 + 5 | 1 | 14.29 | |
| 5 + 4 | 1 | 14.29 | |
| 5 + 5 | 2 | 28.57 | |
| TNM Stage | n | % | |
| T1A | 1 | 6.25 | |
| T2A | 9 | 56.25 | |
| T2B | 3 | 18.75 | |
| T2C | 3 | 18.75 | |
* No Gleason score was reported for two samples. ** None of the patients presented lymph node invasion or disseminated metastasis at the time of diagnosis.